Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 14/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | PAX8 | Q06710 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.86 |
| ▸ | HTT | P42858 | 2/20 | 0.86 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.86 |
| ▸ | ALPL | P05186 | 1/20 | 0.86 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.86 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.86 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.86 |
| ▸ | XBP1 | P17861 | 1/20 | 0.86 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.86 |
| ▸ | STAT3 | P40763 | 1/20 | 0.86 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.73 |
| ▸ | EZH2 | Q15910 | 2/20 | 0.67 |
| ▸ | CREBBP | Q92793 | 3/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | EGFR | P00533 | 1/20 | 0.58 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15840692 | 0.83 | MAPT (0.73) | MAPTSMN1; SMN2LMNAPAX8KMT2A | |
| SCHEMBL30960971 | 0.80 | EZH2 (1.00) | MAPTSMN1; SMN2LMNAPAX8KMT2A | |
| SCHEMBL15840695 | 0.77 | MAPT (0.74) | MAPTSMN1; SMN2LMNAPAX8KMT2A | |
| SCHEMBL15840779 | 0.75 | MAPT (0.70) | MAPTSMN1; SMN2LMNAPAX8KMT2A | |
| SCHEMBL838415 | 0.75 | MAPT (0.77) | MAPTSMN1; SMN2LMNAPAX8KMT2A | |
| SCHEMBL15840731 | 0.75 | MAPT (0.74) | MAPTSMN1; SMN2LMNAPAX8KMT2A | |
| SCHEMBL837686 | 0.73 | MAPT (0.73) | MAPTSMN1; SMN2LMNAPAX8KMT2A | |
| SCHEMBL30917224 | 0.73 | MAPT (0.73) | MAPTSMN1; SMN2LMNAPAX8KMT2A | |
| SCHEMBL15840708 | 0.71 | MAPT (1.00) | MAPTSMN1; SMN2LMNAPAX8KMT2A | |
| SCHEMBL15840766 | 0.71 | MAPT (1.00) | MAPTSMN1; SMN2LMNAPAX8KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140179681-A1 | METHODS AND COMPOSITIONS OF TARGETED DRUG DEVELOPMENT | Errico, Joseph P. (US) | 2014-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179681-A1 | METHODS AND COMPOSITIONS OF TARGETED DRUG DEVELOPMENT | EGFR, ERBB2, ERBB3 | MAPT 1076/4885SMN1; SMN2 3999/4885LMNA 2183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.